Coluccia Daniel, Wolf Oliver T, Kollias Spyros, Roozendaal Benno, Forster Adrian, de Quervain Dominique J-F
Department of Psychiatry Research, University of Zürich, 8032 Zürich, Switzerland.
J Neurosci. 2008 Mar 26;28(13):3474-8. doi: 10.1523/JNEUROSCI.4893-07.2008.
Conditions with chronically elevated glucocorticoid levels are usually associated with declarative memory deficits. Considerable evidence suggests that long-term glucocorticoid exposure may cause cognitive impairment via cumulative and long-lasting influences on hippocampal function and morphology. However, because elevated glucocorticoid levels at the time of retention testing are also known to have direct impairing effects on memory retrieval, it is possible that such acute hormonal influences on retrieval processes contribute to the memory deficits found with chronic glucocorticoid exposure. To investigate this issue, we examined memory functions and hippocampal volume in 24 patients with rheumatoid arthritis who were treated either chronically (5.3 +/- 1.0 years, mean +/- SE) with low to moderate doses of prednisone (7.5 +/- 0.8 mg, mean +/- SE) or without glucocorticoids. In both groups, delayed recall of words learned 24 h earlier was assessed under conditions of either elevated or basal glucocorticoid levels in a double-blind, placebo-controlled crossover design. Although the findings in this patient population did not provide evidence for harmful effects of a history of chronic prednisone treatment on memory performance or hippocampal volume per se, acute prednisone administration 1 h before retention testing to either the steroid or nonsteroid group impaired word recall. Thus, these findings indicate that memory deficits observed under chronically elevated glucocorticoid levels result, at least in part, from acute and reversible glucocorticoid effects on memory retrieval.
长期糖皮质激素水平升高的情况通常与陈述性记忆缺陷有关。大量证据表明,长期暴露于糖皮质激素可能通过对海马功能和形态的累积和持久影响而导致认知障碍。然而,由于在记忆保持测试时糖皮质激素水平升高也已知对记忆提取有直接损害作用,所以这种急性激素对提取过程的影响有可能导致了慢性糖皮质激素暴露所发现的记忆缺陷。为了研究这个问题,我们检查了24名类风湿性关节炎患者的记忆功能和海马体积,这些患者要么接受低至中等剂量泼尼松(7.5±0.8毫克,均值±标准误)的长期治疗(5.3±1.0年,均值±标准误),要么未接受糖皮质激素治疗。在两组中,采用双盲、安慰剂对照的交叉设计,在糖皮质激素水平升高或基础水平的条件下评估对24小时前所学单词的延迟回忆。虽然该患者群体的研究结果没有为慢性泼尼松治疗史对记忆表现或海马体积本身的有害影响提供证据,但在记忆保持测试前1小时给类固醇组或非类固醇组急性注射泼尼松会损害单词回忆。因此,这些结果表明,在长期糖皮质激素水平升高情况下观察到的记忆缺陷至少部分是由糖皮质激素对记忆提取的急性和可逆作用导致的。